Opiant Pharmaceuticals OPNT

Quarterly report 2022-Q3
added 11-14-2022

Opiant Pharmaceuticals DIO Ratio 2011-2026 | OPNT

Annual DIO Ratio Opiant Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	16.1	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.1	16.1	16.1

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 333.39	-1.77 %	$ 43.7 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.68	1.4 %	$ 1.01 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	-	-	$ 399 M	USA
	Aquestive Therapeutics AQST	120	$ 4.24	2.17 %	$ 453 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.58	-2.03 %	$ 3.13 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.49	0.68 %	$ 397 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain